Edit Home Page Content Type: Title: Order:


Immunohistochemistry is a special staining process performed on fresh or frozen breast cancer tissue removed during biopsy. IHC is used to show whether or not the cancer cells have HER2 receptors and/or hormone receptors on their surface. This information plays a critical role in treatment planning. Immunohistochemistry (IHC) is used to characterize intracellular proteins or various cell surfaces in all tissues. Individual markers, or more often panels of various marker proteins, can be used to characterize various tumor subtypes, confirm tissue of origin, distinguish metastatic from primary tumor, and provide additional information which may be important for prognosis, predicting response to therapy, or evaluating residual tumor post-treatment. There is a growing list of available antibodies, which contribute to the broader utility of immunohistochemistry for solving diagnostic problems or for determining prognosis and response to therapy in breast pathology.


    Related Conference of Edit Home Page Content Type: Title: Order:

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Edit Home Page Content Type: Title: Order: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in